MediClin Fachklinik Rhein

MediClin Fachklinik Rhein is owned by MediClin.

MediClin is a company listed under the stock ticker MED (DE).

They are in:

• Healthcare50%
• Biotechnology50%

View the org chart displaying its 3 main executives

Most searched biographies at MediClin Fachklinik Rhein

• Sebastian Klute, Commercial Director and Managing Director
• Mario Siebler, Chief Clinical Officer, Neurology
• Roger Marx, Chief Clinical Officer, Cardiology

Popular executive movements at MediClin

• Thomas Piefke has joined the company as Member of Management Board, Post-Acute Segment  (posted on September 22 2023).

Create your alert
to follow the executive moves at MediClin Fachklinik Rhein.

MediClin has 2,281 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by MediClin Fachklinik Rhein

Social media about MediClin Fachklinik Rhein

• MediClin Fachklinik Rhein on Wikipedia, Google News & Yahoo Finance
• MediClin Fachklinik Rhein on LinkedIn, Twitter & YouTube

Contact by email its executives including Sebastian Klute

Call MediClin Fachklinik Rhein at +49...

View the org chart

Register to receive your alert

Report an error